NBIONascent Biotech, Inc.
Oct 15, 2026 — Strategic Alternatives / Shell Repurposing
Chart by TradingViewThe schedule
- Thu15Oct
A critical late-2026 window where management must either execute a reverse merger or face delisting, testing the $0.00 floor.
- Fri13Nov
The Q3 2026 earnings delivery assessing ongoing listing viability from the $0.00 base.
